Desai, R.; Alaroud, A.A.; Preet, G.; Astakala, R.V.; Ebel, R.; Jaspars, M.
Deep-Sea Marine Metabolites as Promising Anti-Tubercular Agents: CADD-Guided Targeting of the F420-Dependent Oxidoreductase. Mar. Drugs 2026, 24, 58.
https://doi.org/10.3390/md24020058
AMA Style
Desai R, Alaroud AA, Preet G, Astakala RV, Ebel R, Jaspars M.
Deep-Sea Marine Metabolites as Promising Anti-Tubercular Agents: CADD-Guided Targeting of the F420-Dependent Oxidoreductase. Marine Drugs. 2026; 24(2):58.
https://doi.org/10.3390/md24020058
Chicago/Turabian Style
Desai, Ria, Amane A. Alaroud, Gagan Preet, Rishi Vachaspathy Astakala, Rainer Ebel, and Marcel Jaspars.
2026. "Deep-Sea Marine Metabolites as Promising Anti-Tubercular Agents: CADD-Guided Targeting of the F420-Dependent Oxidoreductase" Marine Drugs 24, no. 2: 58.
https://doi.org/10.3390/md24020058
APA Style
Desai, R., Alaroud, A. A., Preet, G., Astakala, R. V., Ebel, R., & Jaspars, M.
(2026). Deep-Sea Marine Metabolites as Promising Anti-Tubercular Agents: CADD-Guided Targeting of the F420-Dependent Oxidoreductase. Marine Drugs, 24(2), 58.
https://doi.org/10.3390/md24020058